Challenges in the Multidisciplinary Management of Pediatric Patients with Intestinal Failure During the COVID-19

Pediatric Annals
|July 20, 2022
PubMed

Insights

The COVID-19 pandemic disrupted pediatric intestinal failure care, impacting central venous catheter management, clinic visits, and surgical timelines, leading to significant challenges for affected children and families.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Disease Epidemiology
  • Healthcare Management

Background:

  • The COVID-19 pandemic significantly altered healthcare delivery globally.
  • Pediatric patients with intestinal failure require complex, multidisciplinary care.
  • Pre-existing vulnerabilities in this patient population may have been exacerbated by pandemic-related disruptions.

Purpose of the Study:

  • To analyze the multifaceted impacts of the COVID-19 pandemic on the care of pediatric patients with intestinal failure.
  • To identify specific challenges faced in managing central venous catheters, clinic visits, and surgical interventions.
  • To assess the broader consequences on patient outcomes and emotional well-being.

Main Methods:

  • Review of clinical management protocols and supply chain data during the pandemic.
  • Analysis of patient care timelines, including clinic visit frequency and surgical scheduling.
  • Qualitative assessment of emotional and psychosocial impacts on patients and families.

Main Results:

  • Disruptions in personal protective equipment and supplies affected central venous catheter home care.
  • Reduced in-person visits led to care delays and hindered progress toward enteral autonomy.
  • Emotional distress among chronically ill children and families was significant.
  • Delayed surgical interventions potentially postponed parenteral nutrition weaning.

Conclusions:

  • The COVID-19 pandemic presented substantial challenges to the multidisciplinary care of pediatric intestinal failure.
  • The full long-term effects of these disruptions on patient outcomes remain to be determined.
  • Adaptations in care delivery are necessary to mitigate future pandemic-related impacts.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
218
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
284
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
272
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
142
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
437